title: Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function.
abstract: We reported previously that predelivery of the anti-oxidant gene heme oxygenase-1 (HO-1) to the heart by adeno associated virus (AAV) markedly reduces injury after acute myocardial infarction (MI). However, the effect of HO-1 gene delivery on postinfarction recovery has not been investigated. In the current study, we assessed the effect of HO-1 gene delivery on post-MI left ventricle (LV) remodeling and function using echocardiographic imaging and histomorphometric approaches. Two groups of Sprague-Dawley rats were injected with 4 x 10(11) particles of AAV-LacZ (control) or AAV-hHO-1 in the LV wall. Eight wk after gene transfer, the animals were subjected to 30 min of ischemia by ligation of left anterior descending artery (LAD) followed by reperfusion. Echocardiographic measurements were obtained in a blinded fashion prior and at 1.5 and 3 months after I/R. Ejection fraction (EF) was reduced by 13% and 40% in the HO-1 and LacZ groups, respectively at 1.5 months after MI. Three months after MI, EF recovered fully in the HO-1, but only partially in the LacZ-treated animals. Post-MI LV dimensions were markedly increased and the anterior wall was markedly thinned in the LacZ-treated animals compared with the HO-1-treated animals. Significant myocardial scarring and fibrosis were observed in the LacZ-group in association with elevated levels of interstitial collagen I and III and MMP-2 activity. Post-MI myofibroblast accumulation was reduced in the HO-1-treated animals, and retroviral overexpression of HO-1 reduced proliferation of isolated cardiac fibroblasts. Our data indicate that rAAV-HO-1 gene transfer markedly reduces fibrosis and ventricular remodeling and restores LV function and chamber dimensions after myocardial infarction.
authors.affiliation: Department of Physiology, Queen's University, Kingston, Ontario, Canada.
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Liu
authors.forename: Alok S
authors.initials: AS
authors.lastname: Pachori
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Ward
authors.forename: J Paul
authors.initials: JP
authors.lastname: Davis
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Gnecchi
authors.forename: Deling
authors.initials: D
authors.lastname: Kong
authors.forename: Lunan
authors.initials: L
authors.lastname: Zhang
authors.forename: Jared
authors.initials: J
authors.lastname: Murduck
authors.forename: Shaw-Fang
authors.initials: SF
authors.lastname: Yet
authors.forename: Mark A
authors.initials: MA
authors.lastname: Perrella
authors.forename: Richard E
authors.initials: RE
authors.lastname: Pratt
authors.forename: Victor J
authors.initials: VJ
authors.lastname: Dzau
authors.forename: Luis G
authors.initials: LG
authors.lastname: Melo
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism; D005347:Fibroblasts; D005355:Fibrosis / Q000235:genetics / Q000473:pathology / Q000628:therapy; D015971:Gene Expression Regulation, Enzymologic; D015316:Genetic Therapy; D006352:Heart Ventricles / Q000033:anatomy & histology; D051547:Heme Oxygenase-1 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000235:genetics / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D016276:Ventricular Function; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: D003094:Collagen; D051547:Heme Oxygenase-1